QuickView for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=86A2AA8A39E51C0F450049D37E597C04;jsessionid=C1188DFB6C25D0C9A6AAC30CD302840A;jsessionid=4FD711A71D7C22919E2D55A0F42BB902;jsessionid=5949D3558B8D9928694B36BA2CC0F055;jsessionid=C3BCC6DC721B6DEDA959F3AA20FC71E2;jsessionid=8603ACE857E25C7328F04C30BE112DCB (gene)

1. Thymic stroma and TFII-I: towards new targeted therapies.
2. Proteomic analysis of SRF associated transcription complexes identified TFII-I as modulator of SRF f…
3. Structural basis for evolutionarily conserved interactions between TFIIS and Paf1C.
4. The TFIIS N-terminal domain (TND): a transcription assembly module at the interface of order and dis…
5. Identification of novel regulatory NFAT and TFII-I binding elements in the calbindin-D28k promoter i…

There were no clinical trials for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=86A2AA8A39E51C0F450049D37E597C04;jsessionid=C1188DFB6C25D0C9A6AAC30CD302840A;jsessionid=4FD711A71D7C22919E2D55A0F42BB902;jsessionid=5949D3558B8D9928694B36BA2CC0F055;jsessionid=C3BCC6DC721B6DEDA959F3AA20FC71E2;jsessionid=8603ACE857E25C7328F04C30BE112DCB